Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021

被引：11

作者：

Indenbaum, Victoria ^{[1
]}

Lustig, Yaniv ^{[1
,2
]}

Mendelson, Ella ^{[1
,2
]}

Hershkovitz, Yael ^{[3
]}

Glatman-Freedman, Aharona ^{[2
,3
]}

Keinan-Boker, Lital ^{[3
,4
]}

Bassal, Ravit ^{[2
,3
]}

机构：

[1] Minist Hlth, Cent Virol Lab, Ramat Gan, Israel

[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel

[3] Sheba Med Ctr, Israel Ctr Dis Control, Minist Hlth, Ramat Gan, Israel

[4] Univ Haifa, Sch Publ Hlth, Haifa, Israel

来源：

EUROSURVEILLANCE | 2021年 / 26卷 / 48期

关键词：

SYNDROME CORONAVIRUS 2;

D O I：

10.2807/1560-7917.ES.2021.26.48.2101040

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 to than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.

引用

页数：5

共 44 条

[41] Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data (vol 397, pg 1819, 2021)
Haas, E. J.
Angulo, F. J.
McLaughlin, J. M.
LANCET, 2021, 398 (10296): : 212 - 212
[42] COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020
Angel Vila-Corcoles
Eva Satue-Gracia
Angel Vila-Rovira
Cinta de Diego-Cabanes
Maria Jose Forcadell-Peris
Immaculada Hospital-Guardiola
Olga Ochoa-Gondar
Josep Basora-Gallisa
BMC Public Health, 21
[43] COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March-June 2020
Vila-Corcoles, Angel
Satue-Gracia, Eva
Vila-Rovira, Angel
de Diego-Cabanes, Cinta
Forcadell-Peris, Maria Jose
Hospital-Guardiola, Immaculada
Ochoa-Gondar, Olga
Basora-Gallisa, Josep
BMC PUBLIC HEALTH, 2021, 21 (01)
[44] References 1 Patel P, Hiam L, Sowemimo A, Devakumar D, McKee M. Ethnicity and covid-19. BMJ. 2020;369:m2282. 2 Pareek M, Bangash MN, Pareek N, et al. Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020;395(10234): 1421-1422. 3 Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of COVID-19? BMJ. 2020;369:m1548. 4 Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711-1724. 5 Public Health England. Disparities in the risk and outcomes of COVID-19. 2020. 6 Office for National Statistics. Updating ethnic contrasts in deaths involving the coronavirus (COVID-19), England: 24 January 2020 to 31 March 2021. 2021.
Irizar, Patricia
Pan, Daniel
Kapadia, Dharmi
Becares, Laia
Sze, Shirley
Taylor, Harry
Amele, Sarah
Kibuchi, Eliud
Divall, Pip
Gray, Laura J.
Nellums, Laura B.
Katikireddi, Srinivasa Vittal
Pareek, Manish
ECLINICALMEDICINE, 2023, 57

← 1 2 3 4 5 →